THIS Sunday (27) marks the day late great filmmaker Yash Chopra was born, and October 12 is his death anniversary.
The prolific producer/director will be remembered on both occasions by Bollywood fans, the film fraternity and all those he influenced in his own unique way across the decades.
Most will recall how incredibly amazing the influential filmmaker was, and to mark the occasion, Eastern Eye presents 20 of the most awesome things he did during his decades-long career.
Magnificent seven: From his first film Dhool Ka Phool in 1959 to his final offering Jab Tak Hain Jaan in 2012, the filmmaker delivered a hit Bollywood film in seven different decades and this achievement will likely never be matched.
Religious tolerance: Chopra’s successful directorial debut Dhool Ka Phool was way ahead of its time. The film’s message of religious harmony and humanity resonates more than 60 years later.
Fabulous formulas: With his 1965 blockbuster Waqt, the filmmaker reintroduced the lost-and-found formula back into Bollywood in a big way along with popularising multi-starrers. The film would influence countless blockbusters that followed, which included most 70s classics.
Song-less success: Hindi films almost exclusively being musicals didn’t stop the filmmaker from giving audiences the path-breaking suspense thriller Ittefaq (1969). It had no songs but surprised everyone by becoming a huge success.
Studio launch: In 1970, he launched Yash Raj Films, which would become the most successful banner in Bollywood history. In the past 50 years, the production house has delivered blockbuster hits, launched new talent, built a giant studio and expanded the horizons of Hindi cinema.
Bold subjects: His 1973 Daag: A Poem of Love became the first commercial Bollywood film to explore bigamy and had perhaps the most unexpected ending at the time, with the hero going off with both leading ladies. Chopra would make these kind of brave choices throughout his career, something which set him apart from other filmmakers.
Deewar: The 1975 classic is one of the greatest Bollywood films ever made and Amitabh Bachchan would later say that in many ways it was the best project of his career. The all-kinds-of-awesome film gave Bollywood’s greatest star his career-defining role and consolidated his position as the undisputed king.
Kabhi Kabhie: What makes this 1976 classic incredible is that Chopra delivered one of the all-time great romantic movies at a time when the action genre was dominating Bollywood. That takes some serious skill and self-belief.
Tackling taboos: Chopra had never shied away from subjects considered taboo. He did that brilliantly with his 1977 production Doosra Aadmi, which was way ahead of its time and revolved around an older woman falling for a younger man.
New talent: The filmmaker supported new talent throughout his career and that included launching Poonam Dhillon as a leading lady in his 1979 home production Noorie. The banner he founded would kickstart the career of many more stars including Anushka Sharma, Ranveer Singh, Saif Ali Khan, Arjun Kapoor, Parineeti Chopra and Vaani Kapoor.
Eye-popping triangle: It remains a mysteryhow Chopra managed to cast the real-life love triangle of Amitabh Bachchan, Jaya Bachchan and Rekha in the lead roles in Silsila (1981), but it was an incredibly audacious feat.
Star-maker: The filmmaker helped turn many actors into movie mega-stars. This included Anil Kapoor with Mashaal (1984), which helped propel him to the very top; and Shah Rukh Khan with Dilwale Dulhania Le Jayenge (1995), which turned him into the king of Bollywood.
Swiss hit: With his 1989 romance Chandni, Chopra not only reintroduced romance back into Bollywood in a big way, but also popularised Switzerland as a shooting destination, which subsequently helped tourism skyrocket in the country. It also inspired other Bollywood filmmakers to shoot more films at exotic locations abroad.
Perfect partnerships: Whether it was with musicians, lyricists and cinematographers or with stars, Chopra had some truly awesome partnerships throughout his career. The two greatest were arguably with superstars Amitabh Bachchan and Shah Rukh Khan. He gave them some of their most successful films, including Deewar, Kabhi Kabhie, Trishul, and Silsila (Bachchan); and Darr, Dilwale Dulhania Le Jayenge, Dil To Pagal Hai and Veer-Zaara (Shah Rukh).
Original love story: There have been countless love triangles in Bollywood, but the most original ever was delivered by the visionary filmmaker with 1991 cult classic Lamhe, where a man is torn between a dead older woman he loved in his youth and her younger identical-looking daughter.
Making of a mogul: The most powerful Bollywood movie mogul of the modern era is Aditya Chopra and it is all thanks to his father. The legendary filmmaker launched his son as a writer/director with Dilwale Dulhania Le Jayenge and then helped shape him into the most successful Bollywood producer of all time, which would help Hindi cinema go global.
Madan magic: The visionary filmmaker always had an incredible ear for great music and incredible lyrics. But he took it a step further by taking unfinished compositions of late music director Madan Mohan, who had died decades earlier, and using them in the Veer-Zaara (2004) soundtrack to stunning effect.
Inspiring actors: Whether it was getting mega-star Rajesh Khanna to play a bigamist (Daag), making Amitabh Bachchan age in Kabhi Kabhie, getting Shah Rukh Khan to play a crazed stalker in Darr or break his no-kissing rule in Jab Tak Hain Jaan, Chopra regularly got big stars tostep out of the comfort zone.
Girl power: Most actresses wanted to become a Yash Chopra heroine because he always gave them something substantial to do. They were never just eye-candy in his films and had impactful roles, including being the main protagonists. Perfect examples include Silsila, Chandni, Lamhe, Darr, Dil To Pagal Hai and Veer-Zaara.
Body of work: Last but not least, the visionary filmmaker left an incrediblebody of work that has entertained audiences across different generations and will continue to do so for many years to come. That is why he is rightfully celebrated every year on his birth and death anniversaries. We at Eastern Eye also salute him.
Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
A new discount deal with UK suppliers will limit the increase for patients.
Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
NHS pricing remains unaffected due to separate arrangements.
Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.
Why the price rise was announced
Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.
Discount deal for UK suppliers
The revised agreement will see the top-dose price set at £247.50 for suppliers. While pharmacies and private providers will still add their own margins, the increase for patients is now likely to remain under 50% for higher doses, and even lower for smaller doses.
Eli Lilly confirmed:
“We are working with private providers on commercial arrangements to maintain affordability and expect these to be passed onto patients when the change is effective on 1 September.”
Impact on consumers
Around 1.5 million people in the UK are currently on weight-loss drugs, with more than half using Mounjaro. Most of these patients—around 90%—pay privately through online services or high street pharmacies.
Prices vary between providers, depending on the level of lifestyle and dietary support offered alongside the injections.
Olivier Picard of the National Pharmacy Association said:
“This rebate will mitigate some of the impact of the increase, but patients should still anticipate seeing a rise in prices from 1 September.”
NHS pricing unchanged
The deal does not affect the NHS, which has secured its own heavily-discounted price for patients prescribed the weekly injection.
Mounjaro works by helping patients feel fuller for longer, reducing food intake and supporting weight loss of up to 20% of body weight.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)
CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.
GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.
The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. Research estimates chickenpox in childhood leads to £24 million in lost income and productivity annually.
Minister of State for Care, Stephen Kinnock, said: “We’re giving parents the power to protect their children from chickenpox and its serious complications, while keeping them in nursery or the classroom where they belong and preventing parents from scrambling for childcare or having to miss work. This vaccine puts children’s health first and gives working families the support they deserve. As part of our Plan for Change, we want to give every child the best possible start in life, and this rollout will help to do exactly that.”
Dr Gayatri Amirthalingam, Deputy Director of Immunisation at the UK Health Security Agency, said: “Most parents probably consider chickenpox to be a common and mild illness, but for some babies, young children and even adults, chickenpox can be very serious, leading to hospital admission and tragically, while rare, it can be fatal. It is excellent news that from next January we will be introducing a vaccine to protect against chickenpox into the NHS routine childhood vaccination programme – helping prevent what is for most a nasty illness and for those who develop severe symptoms, it could be a life saver.”
Amanda Doyle, National Director for Primary Care and Community Services at NHS England, said: “This is a hugely positive moment for families as the NHS gets ready to roll out a vaccine to protect children against chickenpox for the first time, adding to the arsenal of other routine jabs that safeguard against serious illness.”
The eligibility criteria will be set out in clinical guidance, and parents will be contacted by their GP surgery if their child is eligible.
WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.
Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.
“For so long, so many women haven’t been listened to by the world of medicine,” Munchetty said. “I knew this from my own experience of not being given adequate pain relief, or waiting years for a diagnosis. My motivation was to help women and people who love women to advocate better for women’s health.”
The book blends Munchetty’s personal journey with the voices of other women who have faced similar struggles, alongside expert insights from medical professionals. Its purpose, she said, is clear: to empower people to fight for their health.
“We need to be unafraid of saying how we have been weakened by our symptoms,” the BBC presenter said.
“Too often, we try to keep afloat, keep our head above water, but we don’t want to seem weak. That needs to change.”
Munchetty’s candour is striking. She describes the shame of being told her excruciating periods were “just normal,” leaving her to feel weak and whiny for struggling.
“You might as well have told me people have heart attacks while I’m having a heart attack,” she said. “Debilitating pain is serious — it may not be lifelimiting, but it is life-impacting.”
Her determination to challenge that culture led to her giving evidence in parliament, contributing to what became a Women and Equalities Committee report, published in December 2024.
The report made headlines for its stark conclusion: medical misogyny exists.
For Munchetty, seeing that phrase in black and white was transformative. “It was almost self-affirming,” she said. “We now know it’s there, so we can challenge it. Women can say: I know my body, I know there’s not enough research, and I am entitled to push for answers.”
The parliamentary report went further than acknowledgement. It called for ring-fenced funding for women’s health hubs, better training for GPs, and greater investment in research into reproductive conditions like adenomyosis and endometriosis.
It highlighted how symptoms are routinely dismissed as “normal,” delaying diagnosis and disrupting women’s careers, education and daily lives. Munchetty wrote in her book — referencing the report — that medical misogyny is not about blaming individual doctors, but about challenging a system built on insufficient research into women’s bodies.
“It gives women the language and the confidence to not just be heard, but to insist on being taken seriously,” she wrote.
Her book also tackles the additional barriers faced by women from minority communities, who may be discouraged by stigma or embarrassment from speaking about menstruation or menopause. To them, Munchetty has a clear message: “You are so much more valuable than you realise. If you don’t prioritise your health, you are lessening your ability to hold up everyone around you.”
Those featured in the book are friends, colleagues, charities and everyday women who contributed their stories, many for the first time. “I was surprised at how many friends are in that book with such powerful experiences,” Munchetty said.
“It told me all the more that we’re not speaking about it, and that it is sadly so very common.”
At a launch event for the book, contributors, family and experts filled the room with what Munchetty describes as an “electric and inspiring atmosphere.”
She said, “It was full of joy, of women who felt safe to speak up and be heard. This is not a whiny book — it’s a positive book. People felt they were part of making things better, part of this women’s health revolution.”
For Munchetty, writing the book was exhausting, but transformative, she said.
“I never thought I’d be an author. I’m a journalist. But this is journalism — facilitating people’s stories to be told powerfully and truthfully. People trusted me, and I’m proud of that.”
And Munchetty’s aim is for the book to be a tool for change: arming women with the language, confidence and strategies to advocate for their health.
“It’s not easy to admit you need help, and it’s not instinctive for women to prioritise themselves,” she said. “But this book will help you do that. It’s the silent friend who has your back and gives you strength.”
It’s Probably Nothing - Critical Conversations on the Women’s Health Crisis is now available in all good bookshops
The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.
The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”
Several dignitaries were honoured at the ceremony, including Cllr Anjana Patel, Mayor of Harrow; Anuradha Pandey, Hindi and Cultural Attaché at the High Commission of India; Kamakshi Jani of the Royal Navy; Councillors Janet Mote, Nitin Parikh and Mina Parmar; Krishnaben Pujara, Chairperson of ALL UK; and Truptiben Patel, President of the Hindu Forum of Britain.
Organisers said the launch marks the beginning of a new spiritual and cultural hub for London’s Hindu community, offering a centre for devotion, learning and community service.
Martin Dickie has announced his departure from BrewDog and the alcohol industry.
He co-founded the Ellon-based brewer with James Watt in 2007.
Dickie cited family time and personal reasons for his exit.
His departure follows recent bar closures as part of a company restructuring.
BrewDog confirmed no further leadership changes will follow.
BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.
Early beginnings
Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.
Leadership changes
James Watt stepped down as chief executive last year after 17 years in the role, moving into a non-executive position as “captain and co-founder.” Dickie’s exit marks another major shift in the company’s founding leadership.
Dickie’s statement
“Leaving BrewDog isn’t easy, but I’m ready to spend less time travelling and spend some more time at home with my young family,” Dickie said. He added: “It has been an honour to have worked with incredible, like-minded colleagues who live in a world of flavour and experimentation. In James Taylor and Lauren Carrol, BrewDog is in very strong hands and I will always remain a massive fan.”
Company response
BrewDog chief executive James Taylor praised Dickie’s contribution, highlighting his focus on product quality, workplace safety, sustainable supplier relationships, and new product development. “Martin’s contributions to BrewDog have been immeasurable,” Taylor said. “His creativity, passion, and relentless drive have shaped our company over the years and inspired countless others in the industry.”
Recent challenges
The announcement comes a month after BrewDog closed ten of its bars, including its flagship Aberdeen Gallowgate site and a Dundee outlet, citing commercial unviability. The company stressed that Dickie’s departure will not result in further leadership changes.